Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and lactacystin

fingolimod hydrochloride has been researched along with lactacystin in 1 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)		Trials
(fingolimod hydrochloride)		Recent Studies (post-2010)
(fingolimod hydrochloride)		Studies
(lactacystin)		Trials
(lactacystin)		Recent Studies (post-2010) (lactacystin)
2,7711572,0629201155

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)lactacystin (IC50)
Proteasome subunit beta type-11Homo sapiens (human)0.259
Proteasome subunit alpha type-7Homo sapiens (human)0.259
Proteasome subunit beta type-1Homo sapiens (human)0.259
Proteasome subunit alpha type-1Homo sapiens (human)0.259
Proteasome subunit alpha type-2Homo sapiens (human)0.259
Proteasome subunit alpha type-3Homo sapiens (human)0.259
Proteasome subunit alpha type-4Homo sapiens (human)0.259
Proteasome subunit beta type-8Homo sapiens (human)0.259
Proteasome subunit beta type-9Homo sapiens (human)0.259
Proteasome subunit alpha type-5Homo sapiens (human)0.259
Proteasome subunit beta type-4Homo sapiens (human)0.259
Proteasome subunit beta type-6Homo sapiens (human)0.259
Proteasome subunit beta type-5Homo sapiens (human)1.2498
Proteasome subunit beta type-10Homo sapiens (human)0.259
Proteasome subunit beta type-3Homo sapiens (human)0.259
Proteasome subunit beta type-2Homo sapiens (human)1.7545
Proteasome subunit alpha type-6Homo sapiens (human)0.259
Splicing factor 3B subunit 3Homo sapiens (human)3.481
Proteasome subunit alpha-type 8Homo sapiens (human)0.259
Proteasome subunit beta type-7Homo sapiens (human)0.259

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morley, SJ; Pain, VM1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and lactacystin

ArticleYear
Proteasome inhibitors and immunosuppressive drugs promote the cleavage of eIF4GI and eIF4GII by caspase-8-independent mechanisms in Jurkat T cell lines.
    FEBS letters, 2001, Aug-17, Volume: 503, Issue:2-3

    Topics: Acetylcysteine; Apoptosis; Calpain; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Eukaryotic Initiation Factor-4G; fas Receptor; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Jurkat Cells; Leupeptins; Multienzyme Complexes; Peptide Fragments; Peptide Initiation Factors; Propylene Glycols; Proteasome Endopeptidase Complex; Sphingosine; T-Lymphocytes

2001